Thursday, February 6, 2025

Kemin Biologics partners to launch vaccine to protect Peruvian industry against AI

Must read

DES MOINES, Iowa — Kemin Industries will launch its MEFLUVAC H5 PLUS 8 vaccine in partnership with ilender in Latin America to assist in building immunity against the highly pathogenic avian influenza.

Kemin Biologics, the global veterinary vaccine division of Kemin, debuted the new vaccine at an event in Peru on Oct. 30 in the cities of Lima, Trujillo and Chincha. At this event, policy and distribution stakeholders, along with customers from the poultry meat and layer industries, gathered to discuss vaccinology and risk management programs. The industry leaders focused on the importance of addressing major pathogens that compromise animal performance. . .

Register or Login to keep reading

Thank you for your interest in accessing the complete content. To continue reading, please register for free. By registering, you'll gain full access to our valuable resources, updates, and insights.

If you already have an account please Log In.

More articles

Latest article